Jianke Upgrades Beijing R&D Center, Attracts Top Tech Talent to Drive Smart Healthcare Innovation
VCBeat (WeChat ID: vcbeat) AugustNews on the 29th.Jianke, a pharmaceutical e-commerce platform, announced that its Beijing R&D center hasUndertaking a comprehensive upgrade, relocating to a new site, recruiting a large number of technical talents, and launching new products。
JiankeCEOXie Fangmin revealed to VCBeat that, following the expansion of its Beijing R&D center team, the company has specially invitedExperts in search, image recognition, big data, and artificial intelligence join the company as technical leaders, to comprehensively upgrade the company's technology and products.
Ma Jun, Partner at PGA (Jianke’s investor), stated that Jianke has always been a technology-leading pharmaceutical retail service provider with strong internet DNA. He expressed high appreciation for Jianke’s investment in technology and is optimistic about the vigorous development of its technology center, aiming to build China’s leading pharmaceutical technology platform.
A relevant official from the Beijing Representative Office of Doctors Without Borders stated that close cooperation with Jianke can better facilitate the implementation of international medical services, train more physicians with international-level medical expertise, and promote international medical exchanges.
Jianke Beijing R&D Center Holds Housewarming Ceremony; CEO Xie Fangmin (left) and CFO Zhou Feng (right) Unveil Plaque for New Office
Jianke Beijing R&D Center Expands and Upgrades, Inviting Experts to Serve as Technical Leaders
In January this year, Guan Chong, former CIO of New Oriental and former CTO of Lashou.com, joined Jianke as Senior Vice President of Technology. Under his leadership, a research and development team was established in Beijing. With the accelerated growth of its business, the existing office space can no longer meet the needs of industrial upgrading, making a comprehensive upgrade imperative.
It is reported that the expanded Beijing R&D Center has relocated to Huaxin Building in Chaoyang District, Beijing, with its office space increasing from over 200 square meters to 1,200 square meters. Meanwhile, the company has specially invited and attracted leading technical experts from the industry—including specialists in search, image recognition, big data, and artificial intelligence—to join as technical leaders, aiming to achieve a comprehensive upgrade of its products.
Regarding this upgrade, Xie Fangmin stated, “The comprehensive upgrade of our products and technology signifies that Jianke is not merely an e-pharmacy retailer; we are committed to technology-driven development, leveraging cutting-edge technologies to build Jianke into a smart health service platform.”
Leveraging Proprietary Technology to Launch “Doctor Live Streaming Room”
Online pharmacies fall under the e-commerce sector, where technological upgrading is of paramount importance. It is reported that most members of Jianke’s team have backgrounds in the internet industry. Compared with the development model of traditional chain pharmacies, the significance of Jianke’s self-built e-commerce platform becomes particularly prominent. In March this year, Jianke successfully passed Abbott’s rigorous and high-standard distributor selection process, standing out among numerous domestic competitors to become the exclusive e-commerce sales channel for Abbott’s latest “FreeStyle Libre Flash Glucose Monitoring System” in mainland China. Recently, Jianke’s technical team developed its own live-streaming platform, launching the “Jianke Doctor Live Room” within the Jianke Doctor APP to provide free health education, which has also been widely welcomed and supported by users.
According to Xie Fangmin, CEO, the relocation of Jianke’s Beijing R&D Center represents another step in product upgrading, which is inseparable from technological advancement. Technology serves as the foundation for the development of e-commerce and internet enterprises; to align with current user demands, it is imperative to enhance technological capabilities.
Comprehensive Layout to Achieve the Integration of “Medical Care” and “Pharmaceuticals”
At the beginning of 2017, Xie Fangmin announced that “following Jianke’s $100 million Series A financing in early last year, the company has now completed a total of $150 million in Series A funding.” He further stated that, post-financing, Jianke would continue to prioritize investments in R&D, supply chain development, brand building, management system enhancement, and its internet healthcare strategy.
In fact, as a leading enterprise in China's pharmaceutical e-commerce sector, Jianke has been committed to building the most trustworthy smart health service platform since its establishment in 2006. Currently, Jianke continues to expand its scale of development.
Online, Jianke Online Pharmacy has become consumers’ preferred destination for purchasing medications. In the offline sector, Jianke operates more than 20 physical pharmacies in cities such as Guangzhou and Dongguan, including six DTP (Direct-to-Patient) pharmacies. Regarding its footprint in physical hospitals, Jianke has established four facilities this year: Guangzhou Jingtai Hospital, Wuhan Xiongchu Integrated Traditional Chinese and Western Medicine Hospital, Chongqing Jiulongpo Chronic Disease Management Hospital, and Hainan International Cloud Hospital. Currently, Jianke is preparing to establish a branch office in Shanghai and is undertaking a comprehensive upgrade of its Guangzhou operations.
To further enhance user experience, Jianke has established warehouses in Guangzhou, Wuhan, and Dongguan, and invested RMB 10 million in building new production lines. Once the newly installed equipment is put into operation, shipping capacity will increase by at least threefold.